TrialInternational journal of radiation oncology, biology, physics2021

Neoadjuvant SABR for Renal Cell Carcinoma Inferior Vena Cava Tumor Thrombus-Safety Lead-in Results of a Phase 2 Trial.

Vitaly Margulis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.